• Produktbild: The CAPRISA Clinical Trials: HIV Treatment and Prevention
  • Produktbild: The CAPRISA Clinical Trials: HIV Treatment and Prevention

The CAPRISA Clinical Trials: HIV Treatment and Prevention

Fr. 182.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

29.04.2018

Abbildungen

VI, 24 illus., 23 illus. in color., farbige Illustrationen, schwarz-weiss Illustrationen

Herausgeber

Quarraisha Abdool Karim + weitere

Verlag

Springer

Seitenzahl

243

Maße (L/B/H)

23.5/15.5/1.4 cm

Gewicht

391 g

Auflage

Softcover reprint of the original 1st ed. 2017

Sprache

Englisch

ISBN

978-3-319-83756-7

Beschreibung

Portrait

Quarraisha Abdool Karim, Centre for the AIDS Programme of Research in South Africa (CAPRISA); Department of Epidemiology, Columbia University, New York, USA

Salim S. Abdool Karim, Centre for the AIDS Programme of Research in South Africa (CAPRISA); Department of Epidemiology, Columbia University, New York, USA

Cheryl Baxter, Centre for the AIDS Programme of Research in South Africa (CAPRISA)

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

29.04.2018

Abbildungen

VI, 24 illus., 23 illus. in color., farbige Illustrationen, schwarz-weiss Illustrationen

Herausgeber

Verlag

Springer

Seitenzahl

243

Maße (L/B/H)

23.5/15.5/1.4 cm

Gewicht

391 g

Auflage

Softcover reprint of the original 1st ed. 2017

Sprache

Englisch

ISBN

978-3-319-83756-7

Herstelleradresse

Springer Heidelberg
Tiergartenstr. 17
69121 Heidelberg
DE
buchhandel-buch@springer.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: The CAPRISA Clinical Trials: HIV Treatment and Prevention
  • Produktbild: The CAPRISA Clinical Trials: HIV Treatment and Prevention
  • Part I. Introduction.- Studies Linked to the Evolving HIV Epidemic in South Africa: Informing the CAPRISA Scientific Agenda.- CAPRISA: Establishing A Research Center to Undertake HIV Clinical Trials.- Overview of Clinical Trials.- Part II. CAPRISA Clinical Trials for HIV and HSV-2 Prevention.- Antiretrovirals for HIV Prevention.- Rolling out of tenofovir gel in family planning clinics: the CAPRISA 008 implementation trial.- Conditional cash transfers to reduce HIV risk in young women: the CAPRISA 007 cluster randomised control trial.- HIV vaccine and passive immunity trials.- Part III: CAPRISA Clinical Trials for HIV-TB Treatment.- CAPRISA 003:  Timing of antiretroviral initiation in HIV-TB co-infected patients - The SAPiT Trial.- Scaling up TB-HIV integration in public health clinics: translating research findings into practice.- Part IV: Experiences and lessons learnt from clinical trials in CAPRISA.- Lessons from the AcuteInfection Study:  from Bench to Bedside.- Understanding sexual HIV transmission in women by focusing on the genital mucosa.- Part V: Essential support activities for the conduct of clinical trials.- Good practices in conducting clinical trials: Good Participatory Practice, Good Pharmacy Practice and Good Laboratory Practice.- Grants Management.- Taking science to the people: communication and media strategies for clinical trials.- Looking ahead: What Does the Future Hold for CAPRISA?.- Appendix.- Index.